Skip to main content
30°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ZIVO Bioscience, Inc.
ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
February 06, 2025
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience to Present at The Microcap Conference 2025
January 22, 2025
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities
December 23, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza
December 20, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens
August 23, 2024
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens
July 08, 2024
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study
February 07, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Announces Uplisting to OTCQB Market
January 29, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
January 23, 2024
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
OTC
ZIVO
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
October 30, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Announces Reverse Stock Split
October 26, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
October 03, 2023
From
Zivo Bioscience, Inc.
Via
GlobeNewswire
Tickers
ZIVO
ZIVOW
Trial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
September 19, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 Months
August 16, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food
July 26, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
June 30, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient
May 30, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Receives $1 Million Bridge Financing
April 05, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Announces Results of Study with its Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
February 10, 2023
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech Business
October 24, 2022
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience CEO Issues Letter to Shareholders
September 23, 2022
From
Zivo Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment
August 10, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
Zivo Bioscience Joins Russell Microcap® Index
June 27, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq
April 25, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
ZIVO Bioscience Names Chairman John B. Payne as President and CEO
January 10, 2022
From
ZIVO Bioscience, Inc.
Via
Business Wire
Tickers
ZIVO
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.